DUBLIN--(BUSINESS WIRE)--The "Drug Analysis: Betaseron" drug pipelines has been added to ResearchAndMarkets.com's offering. Betaseron was the first drug to reach the market that modifies the course of ...
SAN DIEGO, September 27, 2005 – Berlex, Inc., a U.S. affiliate of Schering AG Germany (FSE: SCH, NYSE: SHR) today announced updated data from the Betaseron® 16-Year Long-Term Follow-up (16-Year LTF) ...
Betaseron (interferon beta-1b) is a prescription drug used to treat clinically isolated syndrome (CIS) and certain types of multiple sclerosis (MS). This drug can interact with alcohol and other ...
San Diego, CA – Berlex announced today that Betaseron® (interferon beta 1b) remained consistently safe, effective and well tolerated over the long term, according to results of the Betaseron 16-Year ...
WAYNE, N.J., July 11 /PRNewswire/ -- Berlex, Inc. today announced the availability of Betaject(R) 3, a new autoinjection device specifically designed to work with Betaseron(R) (interferon beta-1b) as ...
How do you keep a 22-year-old injectable multiple sclerosis therapy competitive in the face of threats from high-flying oral contenders? Bayer has an idea. The company recently won FDA approval for ...
SAN ANTONIO German drug maker Bayer HealthCare Pharmaceuticals has created an iPhone application that it called the first developed for patients using a specific multiple sclerosis medication, Bayer ...
WHIPPANY, N.J., Sept. 25, 2015 /PRNewswire/ -- Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) approved BETACONNECT, the first and only electronic autoinjector in the ...
Treat a disease even before it's diagnosed? Yes, if the disease is multiple sclerosis, new research shows. An MS diagnosis is complex and often depends on more than one attack of neurological symptoms ...
April 22, 2005 — The U.S. Food and Drug Administration (FDA) and Berlex, Inc., have reminded healthcare professionals via letter of the risk of hepatotoxicity associated with use of interferon beta-1b ...
On May 30, 2017, Bayer announced FDA approval of a supplemental Biologics License Application for Bayer’s myBETAapp™ and BETACONNECT Navigator™. The myBETAapp joins the growing field of medical mobile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results